Skip to content
Search

Latest Stories

Competition watchdog probes PCR test provider Expert Medicals

The competition watchdog has opened a formal investigation into a “possible breach of consumer law” by one of the largest private PCR test providers.

It has launched probe into Expert Medicals following complaints, but the Competition and Markets Authority (CMA) has not yet made any decision on whether the company has broken the law.


The allegations against Expert Medicals are that it has not provided tests and results in a timely manner or at all; has failed to respond to customer complaints; and has refused to issue refunds when due.

The firm has been the subject of numerous complaints both to Citizens Advice and more recently to the CMA.

It no longer appears on the list of testing providers who self-declare that they meet the government’s minimum standards for Covid-19 testing.

Andrea Coscelli, chief executive at the CMA, said: “Millions of people have to buy PCR tests in order to travel. If we find that firms have been misleading customers and failing to provide the service that people have paid for, we stand ready to take action.

“Our actions today are the next steps in our work to ensure the PCR testing market works for consumers and we are preparing to take further action in this sector.”

The CMA has written to 19 more test providers warning them to improve their pricing information or risk action in the future.

It expressed concerns that the 19 firms continue to falsely advertise tests at very low prices and hide information conditions, such as where the tests must be collected from.

This move comes after the CMA sent an open letter to PCR test providers on August 25 warning that a range of harmful practices in the sector could breach consumer protection law.

More For You

Scottish community pharmacist working in high street pharmacy with supportive environment

The PDA wants investment to reach those who deliver services to patients every day

Pic credit: iStock

Funding boost in Scotland “needs to work for not just pharmacy owners but pharmacists too”, says PDA

An increase in funding for community pharmacies in Scotland needs to lead to a greater focus on supporting pharmacists rather than “simply sustain business models”, according to the Pharmacy Defence Association (PDA).

Earlier this week, Community Pharmacy Scotland (CPS) accepted the Scottish government’s initial financial offer for the 2025/26 fiscal year, securing a guaranteed minimum reimbursement of £120 million for community pharmacies — up from £110 million from 2024/25.

Keep ReadingShow less
GP surgery upgrades for annual appointments

The surgeries will have additional space to “see more patients, boost productivity and improve patient care”

Pic credit: iStock

GP surgery upgrades to create 8.3 million more annual appointments

Over 1,000 GP surgeries will have their premises modernised to meet the needs of a further 8.3 million appointments each year, the government has announced.

Backed by a cash injection of over £102 million, the surgeries will have additional space to “see more patients, boost productivity and improve patient care”.

Keep ReadingShow less
Wales boosts funding for pharmacy-led UTI and sore throat test services

The sore throat test (STTT) and treat service will be widely available

Pic credit: istock

Welsh pharmacies receive funding boost for clinical services

Two key clinical services will be available in 99 per cent of community pharmacies across Wales after a boost in funding.

The sore throat test (STTT) and treat service and the urinary tract infection (UTI) service have both benefitted from contractual negotiations between the Welsh Government and Community Pharmacy Wales (CPW).

Keep ReadingShow less
Paul Bennett
Paul Bennett, CEO, Royal Pharmaceutical Society
Paul Bennett, CEO, Royal Pharmaceutical Society

Pharmacists need to take advantage of independent prescribing pathways, says Bennett

Independent prescribing will be a “significant point” in the history of community pharmacy, according to Royal Pharmaceutical Society chief executive Paul Bennett.

Last month, the RPS announced the launch of a comprehensive new prescribing development programme to support pharmacists across all stages of their prescribing careers.

Keep ReadingShow less